Aphria’s (APHA) positive EPS pushes long term investors to buy its cheap shares

Cannabis-based healthcare companies rarely achieve positive EPS and have cheap shares that soar on speculation done by their Investor Relations departments. On the other hand, Aphria (NASDAQ: APHA) plays a fair game in stock exchanges relying on available resources and efforts.

Under $5 APHA is proudly showing its 12 months EPS that gives certain confidence to the stockholders who need dividends as earnings. Since march APHA has grown slowly from $2.25 to as high as $4.69 on a humble average volume of 6,124,293 shares.

One may forecast the APHA’s future in weeks; it will slowly surge to $10 with not high volatility until the winter. What happens next is another story.

Anthony Gonzales

Biotech, Tech, and Crypto reporterAnthony Gonzales brings 3 years of experience in helping grassroots, mid-sized organizations and large institutions strengthen their management and resource generating capacities and effectively plan for the future. He is also a mentor and professional advisor to artists working in all disciplines. He is the gold medalist from St. Marco University of Science and Technology in the Bachelors of Financial Management as well.